Trial updateRetina
A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration
Active, not recruiting. Phase 4. Registered enrolment: 17. Astellas Pharma Inc
Why it matters
Track this study through NCT06970665. No results are posted in this registry record.
The study at a glance
- Registry status
- Active, not recruiting
- Phase
- Phase 4
- Registered enrolment
- 17
- Results posted
- No
- Sponsor
- Astellas Pharma Inc
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.